1. This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More.
Dismiss Notice
You must be a registered member in order to post messages and view/download attached files in this forum.
Click here to register.

Inquiry on Reprocessing Sample Size Justification

Discussion in 'Qualification & Validation (Also 21 CFR Part 11)' started by Bender Biomed, Feb 11, 2016.

  1. Bender Biomed

    Bender Biomed New Member

    Joined:
    Feb 11, 2016
    Messages:
    1
    Likes Received:
    0
    Trophy Points:
    1
    Dear all,

    For devices of similar indications as product code KNW (Gastroenterology-urology biopsy instrument), several microbiology testing labs have mentioned that 3 samples is sufficient for sterilization and cleaning efficacy validation for a 510(k) submission based on previous submissions. Does anyone have examples or advice for justification of similar sample sizes for reprocessing efficacy validation?

    Additionally, the FDA guidance on reprocessing medical devices states, “The number of simulated use cycles that you use [for validation studies] should be scientifically justified”. For devices of similar indications as product code KNW microbiology labs have mentioned that 6 simulated use cycles per device is commonly used. Does anyone have examples of scientific justification for the number of simulated use cycles?

    Any feedback or thoughts on this topic would be greatly appreciated,

    Kind regards
     

Share This Page